Understanding barriers and facilitators to pharmacogenomic testing in chronic pain care

Project Narrative: Pharmacogenomics has the potential to improve medication safety in the treatment of chronic pain—which impacts an estimated 1 in 5 adults; however, testing is rarely ordered. Pain physicians are an understudied group of expert stakeholders. By examining their knowledge, views, and practices with pharmacogenomics, this study will improve our understanding of a) the barriers and facilitators to testing and b) clinical and ethical considerations to guide the use of pharmacogenomics in chronic pain care.